These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 15388474)
41. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Aligholi M; Emaneini M; Jabalameli F; Shahsavan S; Dabiri H; Sedaght H Med Princ Pract; 2008; 17(5):432-4. PubMed ID: 18685289 [TBL] [Abstract][Full Text] [Related]
42. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil. Kuti JL; Kiffer CR; Mendes CM; Nicolau DP Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672 [TBL] [Abstract][Full Text] [Related]
43. [Comparative study of the bactericidal activity of cefepime and cefpirome in association with glycopeptides against Staphylococci sensitive and resistant to methicillin]. Husson MO; Fruchart A; Izard D Pathol Biol (Paris); 1998 Apr; 46(4):279-83. PubMed ID: 9769909 [TBL] [Abstract][Full Text] [Related]
44. [Study on activity of antistaphylococcal antibiotic batumin against methicillin resistant strains of staphylococci]. Churkina LN; Bidnenko SI; Liutko OR; Avdeeva LV; Babenko LA Antibiot Khimioter; 2007; 52(9-10):19-23. PubMed ID: 20583466 [TBL] [Abstract][Full Text] [Related]
45. Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic. Blais J; Lewis SR; Krause KM; Benton BM Antimicrob Agents Chemother; 2012 Mar; 56(3):1584-7. PubMed ID: 22203585 [TBL] [Abstract][Full Text] [Related]
46. Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs. Clark C; Ednie LM; Lin G; Smith K; Kosowska-Shick K; McGhee P; Dewasse B; Beachel L; Caspers P; Gaucher B; Mert G; Shapiro S; Appelbaum PC Antimicrob Agents Chemother; 2009 Apr; 53(4):1353-61. PubMed ID: 19188385 [TBL] [Abstract][Full Text] [Related]
47. Novel cephalosporins 1. Synthesis of 3-benzothiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis. Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K J Antibiot (Tokyo); 2000 May; 53(5):546-50. PubMed ID: 10908120 [No Abstract] [Full Text] [Related]
48. Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis. Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K J Antibiot (Tokyo); 2000 May; 53(5):551-5. PubMed ID: 10908121 [No Abstract] [Full Text] [Related]
49. Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. Hanaki H; Akagi H; Nomura S; Unemi N; Hiramatsu K J Antibiot (Tokyo); 1996 Apr; 49(4):402-4. PubMed ID: 8642007 [No Abstract] [Full Text] [Related]
50. Bactericidal activity of ceftaroline against mature Staphylococcus aureus biofilms. Landini G; Riccobono E; Giani T; Arena F; Rossolini GM; Pallecchi L Int J Antimicrob Agents; 2015 May; 45(5):551-3. PubMed ID: 25661754 [No Abstract] [Full Text] [Related]
54. Quinpristin-Dalfopristin resistance among methicillin-resistant strains of staphylococci. Bhatawadekar S; Chattopadhyay A Indian J Pharmacol; 2010 Feb; 42(1):56. PubMed ID: 20606841 [No Abstract] [Full Text] [Related]
55. In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci. Huang V; Brown WJ; Rybak MJ Antimicrob Agents Chemother; 2004 Jul; 48(7):2719-23. PubMed ID: 15215134 [TBL] [Abstract][Full Text] [Related]
56. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents. Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943 [TBL] [Abstract][Full Text] [Related]
57. Antistaphylococcal activity of dalbavancin, an experimental glycopeptide. Lin G; Credito K; Ednie LM; Appelbaum PC Antimicrob Agents Chemother; 2005 Feb; 49(2):770-2. PubMed ID: 15673763 [TBL] [Abstract][Full Text] [Related]
58. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010). Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953 [TBL] [Abstract][Full Text] [Related]
59. Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin. Hoellman DB; Pankuch GA; Appelbaum PC Antimicrob Agents Chemother; 2004 Oct; 48(10):4037-9. PubMed ID: 15388474 [TBL] [Abstract][Full Text] [Related]